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Background. We elaborated a model that predicts the centiles of the 25(OH)D distribution taking into account seasonal variation.
Methods. Data from two Swiss population-based studies were used to generate (CoLaus) and validate (Bus Sante´) the model. Serum
25(OH)Dwasmeasured by ultra high pressure LC-MS/MS and immunoassay. Linear regressionmodels on square-root transformed
25(OH)D values were used to predict centiles of the 25(OH)D distribution. Distribution functions of the observations from the
replication set predicted with the model were inspected to assess replication. Results. Overall, 4,912 and 2,537 Caucasians were
included in original and replication sets, respectively. Mean (SD) 25(OH)D, age, BMI, and % of men were 47.5 (22.1) nmol/L,
49.8 (8.5) years, 25.6 (4.1) kg/m2, and 49.3% in the original study. The best model included gender, BMI, and sin-cos functions
of measurement day. Sex- and BMI-specific 25(OH)D centile curves as a function of measurement date were generated. The
model estimates any centile of the 25(OH)D distribution for given values of sex, BMI, and date and the quantile corresponding
to a 25(OH)D measurement. Conclusions. We generated and validated centile curves of 25(OH)D in the general adult Caucasian
population. These curves can help rank vitamin D centile independently of when 25(OH)D is measured.
1. Introduction
Vitamin D deficiency causes rickets in infants and osteoma-
lacia in adults and contributes to osteoporotic fracture risk
[1]. Molecular and epidemiological associations of vitamin D
deficiency with other diseases such as cancers, cardiovascular
disease, diabetes, depression, andmultiple sclerosis have been
reported [2–5]. Guessous recently discussed in this journal
the relationship of vitaminDwith extraskeletal complications
[6].
Serum 25-hydroxyvitamin D (25(OH)D) is the major
circulating form of vitamin D. It is currently the best marker
of vitamin D status and is used by clinicians to determine
a patient’s vitamin D status [7]. While the definitions of
adequate vitamin D levels differ, several reports suggested
that vitamin D levels are low and vitamin D deficiency is
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very prevalent in general adult populations [8]. For example,
in Switzerland (latitude 46∘), the prevalence of vitamin D
insufficiency (25(OH)D serum levels between 50 nmol/L and
75 nmol/L) and deficiency (<50 nmol/L) is 36% and 38%,
respectively [9].
Most of the circulating vitamin D is synthesized from
cholesterol following exposure to sunlight ultraviolet B
(UVB), whereas a smaller amount is derived from diet and
dietary supplements [2]. Because diet is a naturally low source
of vitamin D, vitamin D levels are highly dependent on
UVB exposure, evenmore in settings where food fortification
policies are not implemented. Other factors such as body
mass index (BMI), skin pigmentation, and geographical
factors (e.g., latitude, altitude, andmeteorological conditions)
can influence circulating vitamin D levels [10].
The physiological mechanisms of seasonal variation in
vitamin D levels are well described [11, 12]. In studies that
collected seasonal data, the highest 25(OH)D levels were
found in summer and autumn and lowest levels in winter and
spring [9, 11, 13–16].
Gender, age, and fatmass seem to influence 25(OH)D sea-
sonal variations [17]. Surprisingly, international and national
guidelines on vitamin D measure, classification, and substi-
tution do not include seasonal variation in their recommen-
dations [18–20]. A major clinical implication is that seasonal
variation of 25(OH)D can directly influence the diagnosis of
vitamin D insufficiency and deficiency. Currently, a measure
of serum 25(OH)D concentration performed at a given
period of the year by a healthcare provider is used to
reflect the patient’s vitamin D status for the overall year
although 25(OH)D levels could be meaningfully different.
Two previous studies that assessed the effects of seasonal
variation of 25(OH)D on the assessment of vitamin D status
in New Zealand confirmed the need of seasonally adjusted
thresholds for the diagnosis of vitamin D deficiency [17, 21].
Many people were predicted to have suboptimal 25(OH)D
concentrations for a substantial proportion of the year,
despite having apparently adequate concentrations at the time
of testing [17]. We are not aware of such population-based
analysis using European data. A recent study showed that,
even with a comprehensive set of genetic, anthropometric,
dietary, and lifestyle correlates, not more than 32.8% of
the variation in 25(OH)D could be explained in the EPIC-
Germany study and that food intake was only a weak
predictor of 25(OH)D concentrations, while a strong seasonal
fluctuation in 25(OH)D was shown [22].
Recognizing this, we used data from two large
population-based Swiss studies to generate and replicate
a simple tool that could help healthcare providers in
interpreting a patient’s vitamin D status independently
of when the patient’s 25(OH)D was measured, while
taking into account age, gender, and BMI. The aim of the
project was to find a model that predicts the centiles of the
25(OH)D distribution given age, sex, BMI, and date of the
measurement. Such centile curves allow for more precision
compared to usual recommendations since they provide
adjusted predictions. Moreover, such model provides an
insight of 25(OH)D levels at a different time point.
2. Materials and Methods
2.1. Original Dataset, the CoLaus Study. To generate the tool,
we used the data from the CoLaus study (http://www.colaus
.ch). The primary aim of the CoLaus study was to assess the
prevalence of cardiovascular risk factors in the Caucasian
population of Lausanne, Switzerland [23] (latitude 46∘). The
sampling procedure of the CoLaus study has been described
elsewhere [23]. Briefly, the CoLaus study was population-
based and included participants aged 35 to 75 years. The
complete list of the Lausanne inhabitants aged 35–75 years
(n = 56,694 in 2003) was provided by the population register
of the city and served to sample the participants to the
study. A simple, nonstratified random sample of 35% of the
overall population was drawn, 8,121 people were eligible for
interview, and 6,188 participants were finally included in the
cohort (76.2%). Recruitment began in June 2003 and ended
inMay 2006. Data were collected by trained field interviewers
using standardized questionnaires.
2.2. Replication Dataset, the Bus Sante´ Study. To replicate the
tool, we used the data from the Bus Sante´ study.TheBus Sante´
study is an ongoing cross-sectional population-based study
conducted in the State of Geneva (latitude 46∘), Switzerland
(http://epidemiologiepopulation.hug-ge.ch). Participants’ re-
cruitment has been described in detail previously [24].
Briefly, a representative sample of noninstitutionalized res-
idents aged 20 and more years is selected independently
throughout each year by using a standardized procedure
using an annual residential list established by local govern-
ment. The participation rate was 65%. To match with the
CoLaus study period, subjects who participated in the Bus
Sante´ study between 2005 and 2008 were included.
2.3. 25-Hydroxyvitamin D and Covariates. In both stud-
ies, venous blood samples were drawn after an overnight
fast and stored at −80∘C. In the CoLaus study, serum
25(OH)D was measured in a single center by an ultra
high pressure liquid chromatography-tandem mass spec-
trometry (LC−MS/MS) system [25]. In the Bus Sante´ study,
serum 25(OH)D was measured in a single center by using
a commercial one-step immunoassay (Architect 25(OH)D,
Abbott Architect i2000sr). The correlation between these
two methods was determined using 125 serum samples; a
Passing-Bablok regression was performed, resulting in an
intercept of 8.71 95%CI [3.31; 13.55] a slope of 0.86 [0.76; 0.95]
(see Figure S1 in Supplementary Material available online
at http://dx.doi.org/10.1155/2015/168189), which indicates that
LC-MS/MS measurements are slightly lower than Architect
ones if values are higher than 62.07 nmol/L. For lower values,
Architect measurements are higher.
In both studies, weight and height were measured using
standardized procedures. BMI was defined as weight/height2
[kg/m2]. In the CoLaus study, information on personal
medicines, including prescription and self-prescribed drugs,
vitamin, mineral supplements, use of oral contraception, and
hormonal replacement therapy, was collected. This informa-
tion was not available in the Bus Sante´ study. The date of
participation was recorded in both studies.
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The CoLaus study and the Bus Sante´ study complied with
the Declaration of Helsinki and were approved by the local
Institutional Ethics Committees. All participants gavewritten
informed consent.
2.4. Statistical Analysis. To predict the centiles of the
25(OH)D distribution, we applied linear regression models
on the square-root transformed 25(OH)D values. Since nor-
mality and a constant variance (estimated via the residual
variance from the regression) are approximately achieved on
the transformed scale, it is possible to estimate any centile
of the distribution. A back transformation then returns these
centiles on the original scale. We considered various models
to adjust for known determinants of 25(OH)D including
gender, age, BMI, and the day when the measurement was
made (via sine and cosine), including possible interactions
between them, and we selected the best model according
to Bayesian information criterion (BIC). In particular, the
effect of age was negligible once adjusted for the other
characteristics. Thus, age was not included in the final
model, whereas some interactions between BMI and sex
and between date of measurement and sex were included.
Note that the BMI was included as −1/√BMI in our model
to limit the influence of individuals with large BMI. This
transformation has been used by other authors to transform
variables related to obesity towards normality [26]. Because
skin pigmentation influences vitamin D synthesis, analyses
were limited to Caucasians. 25(OH)D levels are influenced
by vitamin D therapy and supplementation. We therefore
excluded participants from the original dataset who reported
vitamin D therapy and supplementation (3.9% of the original
dataset). In both datasets, only participants aged between
35 and 65 years with a BMI between 18 and 40 kg/m2 were
kept, which reduced the sample sizes for the analyses. These
BMI limits approximately correspond to percentiles 1% and
99%. Like elderly (i.e., >75 years old) participants, subjects
with extreme BMI were excluded as they are more likely
to suffer from an underlying disease. To account for the
difference between the two 25(OH)Dmeasurementmethods,
we transformed the 25(OH)Dvalues from theBus Sante´ study
according to the Passing-Bablok regression analysis (on the
square-root transformed 25(OH)D values) performed on 125
random serums analyzed with the two methods.
The best model based on BIC was given as follows:
√25 (OH)D = 𝛽
0
+ 𝛽
1
sin(
2𝜋 (day − 1)
365
) + 𝛽
2
⋅ cos(
2𝜋 (day − 1)
365
)
+ 𝛽
3
sin(
4𝜋 (day − 1)
365
) + 𝛽
4
cos(
4𝜋 (day − 1)
365
)
+ 𝛽
5
𝑡 (BMI) + 𝛽
6
𝑡 (BMI)2
+ 𝛽
7
𝐼 (male) 𝐼 (BMI < 25) (𝑡 (BMI) − 𝑡 (25))2
+ 𝛽
8
𝐼 (female) sin(
2𝜋 (day − 1)
365
)
+ 𝛽
9
𝐼 (female) cos(
2𝜋 (day − 1)
365
) .
(1)
BMI was transformed using an inverse square-root func-
tion 𝑡(𝑥) = −1/√𝑥.
Model’s coefficients were as follows: 𝛽
0
= −2.754 (𝑃 value
= 0.295), 𝛽
1
= −1.077 (𝑃 value < 0.0001), 𝛽
2
= −0.756 (𝑃
value < 0.0001), 𝛽
3
= 0.188 (𝑃 value < 0.0001), 𝛽
4
= 0.025 (𝑃
value = 0.368), 𝛽
5
= −81.08 (𝑃 value = 0.002), 𝛽
6
= −165.6 (𝑃
value = 0.014), 𝛽
7
= −1174 (𝑃 value ≤ 0.0001), 𝛽
8
= 0.218 (𝑃
value < 0.0001), and 𝛽
9
= 0.164 (𝑃 value = 0.003). The model
explained 29% of the variance.
Of note, the equation 𝛽
1
sin(2𝜋(day − 1)/365) +
𝛽
2
cos (2𝜋(day − 1)/365) is equivalent to 𝛽󸀠
1
sin (2𝜋(day −
1)/365 + 𝛽
󸀠
2
) that has been used in previous work by Bolland
et al. [21] with 𝛽
1
= 𝛽
󸀠
1
cos (𝛽󸀠
2
) and 𝛽
2
= 𝛽
󸀠
1
sin (𝛽󸀠
2
). In our
model, we added two supplementary sine-cosine terms that
allow the time between minimum and maximum levels to be
different from 6 months. The lowest predicted values were at
mid-March and the highest at mid-August.
We then used the standard deviation (SD) of the residuals
(𝜎
𝜖
= 1.36) to predict all centiles of the 25(OH)D distribution
given fixed values for sex, BMI, and day of measurement.The
𝛼 centile is given as 𝑦+𝑧
𝛼
𝜎
𝜖
, where 𝑦 is the fitted value and 𝑧
𝛼
is the𝛼 quantile of a standard normal distribution.The square
of this centile returns the value on the original scale.
To validate themodel, we accounted for the fact that some
participants in the Bus Sante´ had vitamin D supplementation
(without knowing which ones). We refitted our regression
model above on the CoLaus participants with and without
vitamin D supplementation (𝑁 = 5,066) and used these
model coefficients to estimate the 25(OH)D values in the
Bus Sante´ study. For each observation, we estimated the
corresponding quantile. Histogram and empirical cumulative
distribution function of the quantiles of the Bus Sante´
observations predicted with the model based on the CoLaus
data were inspected. Quantiles should be approximatively
uniformly distributed between 0 and 1 if the model is correct.
3. Results
Overall, 4,912 subjects were included in the original dataset
(CoLaus study). Participants’ characteristics are shown in
Table 1. The mean (SD) age and mean BMI were 49.8 (8.5)
years and 25.6 (4.1) kg/m2, respectively. Fifty % (2491/4912)
of the participants were women, 14.3% (703/4912) were obese
(i.e., BMI ≥ 30), and 10.1% (251/2491) of women used oral
contraceptive or hormonal replacement. The number (%) of
participants by month varied from 268 (5.5%) to 526 (10.7%)
(see Table S1)with fewer peoplemeasured during the summer
months (May to August).
The mean (SD) 25(OH)D level was 47.6 (22.1) nmol/L
(Table 1). The mean 25(OH)D levels differed by season,
gender, and BMI (see Table S2). Overall, 25(OH)D levels
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were <50 nmol/L and <75 nmol/L in 57.5% and 31.1% of the
participants.
Centile curves for 25(OH)Dpredictedwith themultivari-
ate model as a function of date of measurement for men and
women with a fixed value of BMI are illustrated in Figure 1
expressed as a function of month of measurements and in
Figure S2 expressed as a function of week of measurements.
The interaction between gender and BMI appears clearly
when looking at the quantiles predicted as a function of the
BMI for a given day of measurement, as presented in Figure
S3. August 22 is found to be the daywith the highest predicted
25(OH)D values, for both men and women. The lowest
predicted levels are on March 11 for men and on March 18
for women. This difference is due to the sex-day interaction.
Given values for sex, BMI, and day of measurement, it is
possible to estimate any centile of the 25(OH)D distribution.
For example, the median 25(OH)D value measured on
August 22 of a woman with a BMI of 20 is 69.1 nmol/L.
Another important aspect of this model is that it can be
used to estimate the quantile corresponding to a 25(OH)D
measurement. For example, a man with a BMI of 25 and a
25(OH)D level of 60 nmol/L measured on January 1 will be
on the 88.6% quantile.
Our model fitted the data pretty well, as can be seen in
Figure S4, where the histogram and the empirical cumulative
distribution function of the quantiles predicted by the model
were almost those of a uniform distribution.
3.1. Replication. Overall, 2,537 subjects were included in the
replication dataset (Bus Sante´ study). Participants’ character-
istics are shown in Table 1. The replication sample differed
from the original in several ways. The number (%) of
participants by month varied from 59 (2.3%) to 298 (11.8%)
(see Table S1).
The uncorrected mean 25(OH)D values were higher in
the Bus Sante´ than in CoLaus.Themean (SD) 25(OH)D level
was 50.5 (19.9) nmol/L.Themean 25(OH)D levels differed by
season, gender, and BMI (see Table S2). After correction for
difference inmethods used, themean (SD) 25(OH)D value in
the Bus Sante´ was similar to the mean 25(OH)D in CoLaus
(48.6 nmol/L versus 48.1 nmol/L, 𝑃 value = 0.39, see Table 1).
Histogram and empirical cumulative distribution function of
the quantiles of the Bus Sante´ observations predicted with the
model based on the CoLaus were very close to uniformity
suggesting that the model is correct (see Figure S5). To
check the validity of our prediction, the predicted percentage
of people under a given quantile can be considered. For
example, 12.1% of participants have a predicted 25(OH)D
value under the 10% centile, or 4.1% are predicted under
the 3% centile. These proportions are slightly overestimated
(as shown in the histogram in Figure S5) but close to
correct though.Thehighest difference betweenmeasured and
predicted quantiles is given by the Kolmogorov-Smirnov test
statistic, which was equal to 0.036 (95% CI [0.026; 0.054]).
4. Discussion
Using two large Swiss population-based studies, we generated
and validated centile curves of 25(OH)D in the general
adult population. These curves can help healthcare providers
in interpreting a patient’s vitamin D status independently
of when the patient’s 25(OH)D was measured. We pro-
vided gender- and BMI-specific 25(OH)D centile curves as
25(OH)D level is influenced by these factors. We developed
a free online tool available at http://www.iumsp.ch/charts/
select graph.htm that can be used to determine where a
patient fits compared to a reference population at a given
time.
Given the growing evidence of associations of low vitamin
D levels with several chronic diseases, determining vitamin
D status has gained increasing importance [27], especially
in settings such as in Switzerland where no vitamin D
fortification policy is implemented. Efforts to find a suffi-
ciently predictive model for vitamin D status without using
information on 25(OH)D level have failed and currently there
is no substitute for 25(OH)D testing [28]. While the best
determinant of vitamin D status is the serum concentration
of 25(OH)D, this parameter fluctuates with season and not
considering season-specific 25(OH)D levels can mislead the
diagnosis of vitamin D status. Two studies conducted in New
Zealand previously assessed the effects of seasonal variation
of 25(OH)D on diagnosis of vitamin D sufficiency [17, 21].
In the most recent one, Bolland et al. used the data from
postmenopausal women (𝑁 = 1,606) and from a small
sample (𝑁 = 378) of middle-aged and older men and
found that many people were predicted to have suboptimal
25(OH)D concentrations for a substantial proportion of the
year, despite having apparently adequate concentrations at
the time of testing [21]. Results observed in New Zealand are
however not directly transposable to European settings given
that 25(OH)D levels are influenced by latitude and sunshine
duration. Brown et al. proposed an interesting mathemati-
cal model of 25(OH)D serum using information on food,
supplements, sun, and 25(OH)D levels [29]. Yet, information
on 25(OH)D levels dated from 1998, and compared to this
present study, sample size was smaller and BMIwas not taken
into account. Thus, our work provides information using
more recent data collected in a larger study sample from
Switzerland, a country situated in the center of Europe.
Furthermore, the number of large population-based stud-
ies reporting seasonal data is limited [8, 15, 16, 30], and we
found no study that reported centile curves. Centile curves
present several advantages. Centile curves are routinely used
in clinical medicine to detect extreme values of a measure-
ment of interest [31, 32]. Data used to construct the curves
are representative of the reference population. Centile curves
can take into consideration major factors (e.g., gender, BMI,
and date of measurement) that influence the distribution. In
line with a previous Swiss population-based study [9], age
was not independently associated with 25(OH)D. The lack
of an independent association might be explained, at least in
part, by the upper age limit of the participants (i.e., 75 years)
included in the CoLaus and Bus Sante´ studies and/or by the
adjustment for BMI. Age-related vitamin D deficiency has
been essentially reported among elderly subjects; cutaneous
production of vitamin D is decreased [33] and exposure
to sunshine through outdoor activities reduced in elderly
subjects [34].The effect of age on vitaminDdeficiency among
6 BioMed Research International
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Figure 1: Quantiles of 25(OH)D according to the date of measurement (horizontal units expressed in month of measurements), for men and
women with different BMI values (20, 25, and 30).
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subjects younger than 75 years might be not strong enough
to be captured after adjustment for gender, BMI, and day of
measurement. BMI frequently increases with age [35] and
there are several mechanisms by which vitamin D levels
could be inversely associatedwithBMI including the decrease
of outdoor physical activity, the inadequate diet, and the
sequestration of vitaminD in the cutaneous fat among people
with overweight or obesity [36]. Our results suggest that BMI
and not age is worth considering when interpreting seasonal
variation of 25(OH)D. Nevertheless, only adult participants
between 35 and 65 years were included. When considering
children, adolescents, and elderly people, the age association
might be different from what was observed in the present
study.
While not considering season-specific 25(OH)D levels
biases the assessment of vitamin D status, the benefit of
maintaining optimal 25(OH)D levels throughout the sea-
sons remained to be demonstrated. There is some evidence
suggesting that cycles of suboptimal level of vitamin D
throughout the year are harmful for bone health [37–39],
but such evidence for other health outcomes is little [11, 40].
The observation that not only the parathyroid hormone but
also the active form of vitamin D (i.e., 1,25(OH)2D) parallels
25(OH)D seasonal variation [41] suggests that variation,
if meaningful enough, can influence health outcomes. In
general, any period of vitamin D insufficiency is undesirable
[17, 21, 42].
Finally, given the cost of 25(OH)D testing and the
evidence of overtesting, some insurance and regions have
altered their policies to restrict 25(OH)D testing [28, 43].
In the absence of vitamin D supplementation, our simple
tool, which relies on a single 25(OH)D test, could potentially
decrease healthcare cost by limiting the number of 25(OH)D
tests performed for a given patient throughout a year to
determine vitamin D status.
4.1. Strengths and Limitations. When interpreting the find-
ings of this study, one has to keep in mind its limitations.
First, our results are representative of general and unselected
adult populations in Switzerland. Because vitamin D levels
have been shown to vary between populations, the centile
curves presented in this report are not generalizable to
populations that differ from our source population in terms
of both individual- (e.g., age, ethnicity) and contextual-
determinants of vitamin D levels (e.g., food fortification
policy). Of note, these results are latitude-specific as both
studies were conducted at the same latitude. When deter-
minants of vitamin D levels are similar, our results can
potentially be extrapolated to European countries within the
same range of latitude (45∘–50∘) such as France, Austria, the
southern part of Germany, the northern part of Italy, and
some eastern European countries. For other countries, our
method could be replicated when population-based data are
available. Second, we relied on a single measure of vitamin
D per participant. Third, as previous studies [17, 21], if we
want to predict future values of an individual along the year
given ameasurementmade on a given day, we have to assume
that each participant’s 25(OH)D concentrations throughout
the year would follow a curve similar to that of the overall
population; that is, the correlation between two repeated
measurementsmade on the same subjects in different seasons
would be perfect (1.0). To be able to affine such individual
predictions taking into account that this correlation is not
perfect, data from a longitudinal analysis would be necessary.
While our model was built to fit the seasonal variation
of 25(OH)D at the population level, seasonal variation at
the individual level can differ, notably in individuals who
differ meaningfully from the study population in terms of
vitamin D levels determinants. Fourth, we lack information
on vitamin D therapy or supplementation in the replication
dataset. We corrected the replication dataset 25(OH)D levels
and centile curves using original dataset derived correction
factor. Moreover, the measurement methods were different
between the two datasets.
Another limitation could be the possible time trends of
25(OH)D levels from the data collection up to now. Samples
were collected almost 10 years ago andwe cannot exclude that
population-averaged levels have changed. Yet, trends analyses
of 25(OH)D levels in the Swiss population suggest that levels
have been stable [9].
Our study has several strengths. To generate centile
curves, we used standard reference 25(OH)D method of
measurement (LC-MS/MS).We replicated our findings using
a similar yet different population and a standard commercial
immunoassay. The city of Lausanne (CoLaus study) and
the state of Geneva (Bus Sante´ study) are located 37 miles
away on the same latitude. Reference populations are ideally
composed of individuals assumed to be “normal.” We used
data from noninstitutionalized residents randomly selected
to participate in population-based studies as reference pop-
ulations. Compared to other study designs (clinical trials,
hospital data, and institutions data), this approach mitigates
the risk of having unrepresentative populations. Finally, we
did not rely on healthcare-related administrative data, which
are subject to bias including seasonal testing bias [28].
In conclusion, we used a centile curves approach, which
is well known with growth charts, to generate and validate
a model available as a free online tool that could help
in interpreting vitamin D status independently of when
25(OH)D is measured.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] M. F. Holick, “Vitamin D: important for prevention of osteo-
porosis, cardiovascular heart disease, type 1 diabetes, autoim-
mune diseases, and some cancers,” Southern Medical Journal,
vol. 98, no. 10, pp. 1024–1027, 2005.
[2] M. F. Holick, “Vitamin D deficiency,”The New England Journal
of Medicine, vol. 357, no. 3, pp. 266–281, 2007.
[3] I. Guessous, M. Bochud, O. Bonny, and M. Burnier, “Calcium,
vitamin D and cardiovascular disease,” Kidney and Blood
Pressure Research, vol. 34, no. 6, pp. 404–417, 2011.
8 BioMed Research International
[4] S. Penckofer, J. Kouba, D. E. Wallis, andM. A. Emanuele, “Vita-
min D and diabetes: let the sunshine in,”Diabetes Educator, vol.
34, no. 6, pp. 939–954, 2008.
[5] E. R. Bertone-Johnson, “Vitamin D and the occurrence of
depression: causal association or circumstantial evidence?”
Nutrition Reviews, vol. 67, no. 8, pp. 481–492, 2009.
[6] I. Guessous, “Role of vitamin D deficiency in extraskeletal
complications: predictor of health outcome or marker of health
status?” BioMed Research International, vol. 2015, Article ID
563403, 13 pages, 2015.
[7] K. A. Kennel, M. T. Drake, and D. L. Hurley, “Vitamin D
deficiency in adults: when to test and how to treat,”Mayo Clinic
Proceedings, vol. 85, no. 8, pp. 752–758, 2010.
[8] N. M. van Schoor and P. Lips, “Worldwide vitamin D sta-
tus,” Best Practice and Research: Clinical Endocrinology and
Metabolism, vol. 25, no. 4, pp. 671–680, 2011.
[9] I. Guessous, V. Dudler, N. Glatz et al., “Vitamin D levels and
associated factors: a population-based study in Switzerland,”
Swiss Medical Weekly, vol. 142, 2012.
[10] M. F. Holick, “Vitamin D: a millenium perspective,” Journal of
Cellular Biochemistry, vol. 88, no. 2, pp. 296–307, 2003.
[11] J. D. Maxwell, “Seasonal variation in vitamin D,” Proceedings of
the Nutrition Society, vol. 53, no. 3, pp. 533–543, 1994.
[12] A. R. Webb, L. Kline, and M. F. Holick, “Influence of season
and latitude on the cutaneous synthesis of vitaminD3: exposure
to winter sunlight in Boston and Edmonton will not promote
vitamin D3 synthesis in human skin,” Journal of Clinical
Endocrinology and Metabolism, vol. 67, no. 2, pp. 373–378, 1988.
[13] J. Klenk, K. Rapp,M.D.Denkinger et al., “Seasonality of vitamin
D status in older people in Southern Germany: implications for
assessment,”Age and Ageing, vol. 42, no. 3, Article ID aft042, pp.
404–408, 2013.
[14] M. Kull Jr., R. Kallikorm, A. Tamm, and M. Lember, “Seasonal
variance of 25-(OH) vitamin D in the general population of
Estonia, aNorthern European country,”BMCPublic Health, vol.
9, article 22, 2009.
[15] Z. Lagunova, L. C. Porojnicu, F. Lindberg, S. Hexeberg, and
J. Moan, “The dependency of vitamin D status on body mass
index, gender, age and season,” Anticancer Research, vol. 29, no.
9, pp. 3713–3720, 2009.
[16] S. Levis, A. Gomez, C. Jimenez et al., “Vitamin D deficiency
and seasonal variation in an adult south Florida population,”
Journal of Clinical Endocrinology and Metabolism, vol. 90, no.
3, pp. 1557–1562, 2005.
[17] M. J. Bolland, A. B. Grey, R. W. Ames et al., “The effects of
seasonal variation of 25-hydroxyvitamin D and fat mass on a
diagnosis of vitamin D sufficiency,” The American Journal of
Clinical Nutrition, vol. 86, no. 4, pp. 959–964, 2007.
[18] WHO, Vitamin and Mineral Requirements in Human Nutrition,
World Health Organization, Geneva, Switzerland, 2nd edition,
2005, http://www.who.int/nutrition/publications/mi-cro-nu-
trients/9241546123/en/.
[19] Federal Office for Public Health and Federal Commission
for Nutrition, Vitamin D Deficiency: Evidence, Safety, and
Recommendations for the Swiss Population. Expert Report of
the FCN, Federal Office for Public Health, Zu¨rich, Switzerland,
2012, http://www.bag.admin.ch/org/.
[20] IOM, Dietary Reference Intakes for Calcium and Vitamin
D, 2010, http://www.iom.edu/Reports/2010/Dietary-Reference-
Intakes-for-calcium-and-vitamin-D.aspx.
[21] M. J. Bolland, W. W. Chiu, J. S. Davidson et al., “The effects
of seasonal variation of 25-hydroxyvitamin D on diagnosis of
vitamin D insufficiency,” New Zealand Medical Journal, vol. 121,
no. 1286, pp. 63–74, 2008.
[22] T. Ku¨hn, R. Kaaks, B. Teucher et al., “Dietary, lifestyle, and
genetic determinants of vitaminD status: a cross-sectional anal-
ysis from the European Prospective Investigation into Cancer
and Nutrition (EPIC)-Germany study,” European Journal of
Nutrition, vol. 53, no. 3, pp. 731–741, 2014.
[23] M. Firmann, V. Mayor, P. M. Vidal et al., “The CoLaus
study: a population-based study to investigate the epidemiology
and genetic determinants of cardiovascular risk factors and
metabolic syndrome,” BMC Cardiovascular Disorders, vol. 8,
article 6, 2008.
[24] I. Guessous, M. Bochud, J.-M. Theler, J.-M. Gaspoz, and A.
Peche`re-Bertschi, “1999–2009 Trends in prevalence, unaware-
ness, treatment and control of hypertension in Geneva, Switzer-
land,” PLoS ONE, vol. 7, no. 6, Article ID e39877, 2012.
[25] S. J. Bruce, B. Rochat, A. Be´guin et al., “Analysis and quantifi-
cation of vitamin Dmetabolites in serum by ultra-performance
liquid chromatography coupled to tandem mass spectrometry
and high-resolution mass spectrometry—a method compari-
son and validation,” Rapid Communications in Mass Spectrome-
try, vol. 27, no. 1, pp. 200–206, 2013.
[26] T. Gasser, P. Ziegler, B. Seifert, A. Prader, L. Molinari, and R.
Largo, “Measures of body mass and of obesity from infancy
to adulthood and their appropriate transformation,” Annals of
Human Biology, vol. 21, no. 2, pp. 111–125, 1994.
[27] A. M. Rose, “Vitamin D testing: clinical and laboratory consid-
erations,” Medical Laboratory Observer, vol. 45, no. 5, pp. 8–16,
2013.
[28] A. N. Peiris, B. A. Bailey, B. N. Guha, R. Copeland, and T.
Manning, “Can a model predictive of vitamin D status be
developed from common laboratory tests and demographic
parameters?” Southern Medical Journal, vol. 104, no. 9, pp. 636–
639, 2011.
[29] J. Brown, A. Ignatius, M. Amling, and F. Barvencik, “New
perspectives on vitamin D sources in Germany based on
a novel mathematical bottom-up model of 25(OH)D serum
concentrations,” European Journal of Nutrition, vol. 52, no. 7, pp.
1733–1742, 2013.
[30] T. Hagenau, R. Vest, T. N. Gissel et al., “Global vitamin D levels
in relation to age, gender, skin pigmentation and latitude: an
ecologic meta-regression analysis,” Osteoporosis International,
vol. 20, no. 1, pp. 133–140, 2009.
[31] E. M. Wright and P. Royston, “Calculating reference intervals
for laboratory measurements,” Statistical Methods in Medical
Research, vol. 8, no. 2, pp. 93–112, 1999.
[32] E. M. Wright and P. Royston, “A comparison of statistical
methods for age-related reference intervals,” Journal of the Royal
Statistical Society Series A: Statistics in Society, vol. 160, no. 1, pp.
47–69, 1997.
[33] M. F. Holick, L. Matsuoka, and J. Wortsman, “Age, vitamin D,
and solar ultraviolet,” The Lancet, vol. 334, no. 8671, pp. 1104–
1105, 1989.
[34] F. M. Gloth III, C. M. Gundberg, B. W. Hollis, J. G. Haddad Jr.,
and J. D. Tobin, “Vitamin D deficiency in homebound elderly
persons,” Journal of the American Medical Association, vol. 274,
no. 21, pp. 1683–1686, 1995.
[35] Z. Welon, A. Szklarska, T. Bielicki, and R. M. Malina, “Sex
differences in the pattern of age-dependent increase in the BMI
BioMed Research International 9
from 20-59 years,” American Journal of Human Biology, vol. 14,
no. 6, pp. 693–698, 2002.
[36] J. Wortsman, L. Y. Matsuoka, T. C. Chen, Z. Lu, and M. F.
Holick, “Decreased bioavailability of vitamin D in obesity,”The
American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 690–
693, 2000.
[37] P. B. Rapuri, H. K. Kinyamu, J. C. Gallagher, and V. Haynatzka,
“Seasonal changes in calciotropic hormones, bonemarkers, and
bone mineral density in elderly women,”The Journal of Clinical
Endocrinology&Metabolism, vol. 87, no. 5, pp. 2024–2032, 2002.
[38] H. T. Viljakainen, A. Palssa, M. Ka¨rkka¨inen et al., “A seasonal
variation of calcitropic hormones, bone turnover and bonemin-
eral density in early and mid-puberty girls—a cross-sectional
study,” British Journal of Nutrition, vol. 96, no. 1, pp. 124–130,
2006.
[39] T. R. Hill, D. McCarthy, J. Jakobsen, C. Lamberg-Allardt, M.
Kiely, and K. D. Cashman, “Seasonal changes in vitamin D sta-
tus and bone turnover in healthy Irish postmenopausalwomen,”
International Journal for Vitamin andNutrition Research, vol. 77,
no. 5, pp. 320–325, 2007.
[40] A. Porojnicu, T. E. Robsahm, J. P. Berg, and J. Moan, “Season of
diagnosis is a predictor of cancer survival. Sun-induced vitamin
D may be involved: a possible role of sun-induced Vitamin D,”
The Journal of Steroid Biochemistry and Molecular Biology, vol.
103, no. 3–5, pp. 675–678, 2007.
[41] S. S. Sherman, B. W. Hollis, and J. D. Tobin, “Vitamin D status
and related parameters in a healthy population: the effects of
age, sex, and season,” Journal of Clinical Endocrinology and
Metabolism, vol. 71, no. 2, pp. 405–413, 1990.
[42] R. Vieth, “How to optimize vitamin D supplementation to
prevent cancer, based on cellular adaptation and hydroxylase
enzymology,”Anticancer Research, vol. 29, no. 9, pp. 3675–3684,
2009.
[43] K. Bilinski and S. Boyages, “Evidence of overtesting for vitamin
D in Australia: an analysis of 4.5 years of Medicare Benefits
Schedule (MBS) data,” BMJ Open, vol. 3, no. 6, Article ID
002955, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
